Table 1. Cox proportional hazards regression models in estimating cancer development.
Variables | Overall survival | P | |
---|---|---|---|
HR | 95% | ||
Univariate analysis | |||
CD73 expression | |||
Positive VS negative | 2.472 | 1.367–4.469 | 0.003 |
Gender | |||
Male VS female | 1.017 | 0.512–2.020 | 0.961 |
Age | |||
< 60 VS ≥ 60 | 1.008 | 0.983–1.033 | 0.539 |
Smoking | |||
Yes VS no | 0.790 | 0.378–1.650 | 0.530 |
Drinking | |||
Yes VS no | 0.910 | 0.422–1.962 | 0.811 |
Tumor stage | |||
3–4 VS 1–2 | 1.355 | 1.025–1.791 | 0.033 |
Lymph node metastasis | |||
+ VS − | 1.676 | 1.230–2.282 | 0.001 |
Clinical stage | |||
3–4 VS 1–2 | 1.433 | 1.034–1.986 | 0.031 |
Histological type | |||
Poor VS well-moderate | 1.312 | 0.986–1.744 | 0.062 |
Multivariate analysis | |||
CD73 expression | 2.370 | 1.306–4.466 | 0.005 |
Lymph node metastasis | 1.765 | 1.203–2.348 | 0.002 |
CI, confidence interval; HR, Hazard ratio.